These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 16775597)
1. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Srivastava T; Garola RE; Singh HK Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597 [TBL] [Abstract][Full Text] [Related]
2. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood. Srivastava T; Garola RE; Whiting JM; Alon US Kidney Int; 2003 Apr; 63(4):1374-81. PubMed ID: 12631353 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090 [TBL] [Abstract][Full Text] [Related]
4. The morphological characteristics and expression of cell cycle regulatory proteins in cellular variants of idiopathic focal segmental glomerulosclerosis. Wang SX; Liu G; Zou WZ; Wang HY Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):145-9. PubMed ID: 15100731 [TBL] [Abstract][Full Text] [Related]
5. Cell-cycle mechanisms involved in podocyte proliferation in cellular lesion of focal segmental glomerulosclerosis. Wang S; Kim JH; Moon KC; Hong HK; Lee HS Am J Kidney Dis; 2004 Jan; 43(1):19-27. PubMed ID: 14712423 [TBL] [Abstract][Full Text] [Related]
6. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease. da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279 [TBL] [Abstract][Full Text] [Related]
7. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis. Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926 [TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878 [TBL] [Abstract][Full Text] [Related]
9. Podocyte expression of the CDK-inhibitor p57 during development and disease. Hiromura K; Haseley LA; Zhang P; Monkawa T; Durvasula R; Petermann AT; Alpers CE; Mundel P; Shankland SJ Kidney Int; 2001 Dec; 60(6):2235-46. PubMed ID: 11737597 [TBL] [Abstract][Full Text] [Related]
11. Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Srivastava T; Garola RE; Whiting JM; Alon US Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy. Yang Y; Gubler MC; Beaufils H Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471 [TBL] [Abstract][Full Text] [Related]
13. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS? Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986 [TBL] [Abstract][Full Text] [Related]
14. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies. Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis. Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861 [TBL] [Abstract][Full Text] [Related]
16. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523 [TBL] [Abstract][Full Text] [Related]
17. Dystroglycan in the diagnosis of FSGS. Giannico G; Yang H; Neilson EG; Fogo AB Clin J Am Soc Nephrol; 2009 Nov; 4(11):1747-53. PubMed ID: 19808230 [TBL] [Abstract][Full Text] [Related]
18. Ezrin--a useful factor in the prognosis of nephrotic syndrome in children: an immunohistochemical approach. Ostalska-Nowicka D; Zachwieja J; Nowicki M; Kaczmarek E; Siwinska A; Witt M J Clin Pathol; 2006 Sep; 59(9):916-20. PubMed ID: 16522749 [TBL] [Abstract][Full Text] [Related]
19. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood. Eroglu FK; Orhan D; İnözü M; Duzova A; Gulhan B; Ozaltin F; Topaloglu R Pediatr Int; 2019 Dec; 61(12):1250-1256. PubMed ID: 31513327 [TBL] [Abstract][Full Text] [Related]
20. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]